Search research articles
Contact Us
Filters
Showing results (121-130 of 314) with videos related to
Page
of 32
Sort By:
Journal of Clinical Medicine
|
June 28, 2023
Building Team Medicine in the Management of CNS Metastases
Archit B Baskaran, Robin A Buerki, Osaama H Khan, et al.
Nature Reviews. Neurology
|
December 10, 2009
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller, Roger Stupp, Guido Reifenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2008
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E Hegi, Lili Liu, James G Herman, et al.
Neuro-Oncology
|
October 26, 2012
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice
Michael Weller, Roger Stupp, Monika E Hegi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2021
Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE Trials
Julia Furtner, Michael Weller, Michael Weber, et al.
Cancer Treatment Reviews
|
January 6, 2017
Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review
Stephanie G C Kroeze, Corinna Fritz, Morten Hoyer, et al.
International Journal of Cancer
|
August 23, 2005
Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapy
Khalil Zaman, Robert Driscoll, Diane Hahn, et al.
Journal of Neuro-Oncology
|
February 10, 2018
Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?
Caroline Happold, Thierry Gorlia, L Burt Nabors, et al.
Ophthalmic Genetics
|
April 30, 2011
Chiasmatic infiltration secondary to late malignant transformation of retinoma
Asimina Mataftsi, Leonidas Zografos, Aubin Balmer, et al.
The Oncologist
|
February 16, 2006
Changing paradigms--an update on the multidisciplinary management of malignant glioma
Roger Stupp, Monika E Hegi, Martin J van den Bent, et al.
Page
of 32
Search research articles
Search
Showing results (121-130 of 314) with videos related to
Sort By:
Page
of 32
Journal of Clinical Medicine
|
June 28, 2023
Building Team Medicine in the Management of CNS Metastases
Archit B Baskaran, Robin A Buerki, Osaama H Khan, et al.
Nature Reviews. Neurology
|
December 10, 2009
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller, Roger Stupp, Guido Reifenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2008
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E Hegi, Lili Liu, James G Herman, et al.
Neuro-Oncology
|
October 26, 2012
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice
Michael Weller, Roger Stupp, Monika E Hegi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2021
Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE Trials
Julia Furtner, Michael Weller, Michael Weber, et al.
Cancer Treatment Reviews
|
January 6, 2017
Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review
Stephanie G C Kroeze, Corinna Fritz, Morten Hoyer, et al.
International Journal of Cancer
|
August 23, 2005
Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapy
Khalil Zaman, Robert Driscoll, Diane Hahn, et al.
Journal of Neuro-Oncology
|
February 10, 2018
Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?
Caroline Happold, Thierry Gorlia, L Burt Nabors, et al.
Ophthalmic Genetics
|
April 30, 2011
Chiasmatic infiltration secondary to late malignant transformation of retinoma
Asimina Mataftsi, Leonidas Zografos, Aubin Balmer, et al.
The Oncologist
|
February 16, 2006
Changing paradigms--an update on the multidisciplinary management of malignant glioma
Roger Stupp, Monika E Hegi, Martin J van den Bent, et al.
Page
of 32